Table 2.
Case no. | Lesion | KIT | CD34 | SMA | Desmin | S‐100 | Vimentin | Ki67 labeling index (%) |
---|---|---|---|---|---|---|---|---|
1 | Primary | +++ | +++ | – | – | – | ++ | 1 |
Liver meta | +++ | +++ | – | – | – | ++ | 20 | |
2 | Primary | +++ | +++ | – | – | – | +++ | <1 |
Liver meta | +++ | +++ | – | – | – | +++ | 10 | |
3 | Primary‐L † | + | + | + | – | – | ++ | 2 |
Primary‐H ‡ | +++ | +++ | ++ | – | – | ++ | 14 | |
Liver meta | +++ | +++ | ++ | – | – | ++ | 23 | |
4 | Primary | +++ | +++ | + | – | – | – | 1.2 |
Liver meta | +++ | +++ | + | – | – | – | 4.3 |
Low cellularity area in the primary lesion.
High cellularity area in the primary lesion. +++, Strong staining intensity; +, weak staining intensity; –, negative staining.